Bristol Myers Squibb to Take Part in 41st Annual Goldman Sachs Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) will take part in a fireside chat at the 41st Annual Goldman Sachs Global Healthcare Conference, which will be webcast on June 11, 2020. Chris Boerner, EVP and Chief Commercialization Officer and Nadim Ahmed, EVP and President, Hematology will answer questions about the company at 3 p.m. E.T.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.